Trials / Conditions / Limited Stage Lung Small Cell Carcinoma

Limited Stage Lung Small Cell Carcinoma

8 registered clinical trials studyying Limited Stage Lung Small Cell Carcinoma — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Perioperative Immunotherapy for Resectable Limited-Stage SCLC NCT07109401	Fudan University	Phase 2
Terminated	Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer NCT06140407	Vanderbilt-Ingram Cancer Center	Phase 2
Active Not Recruiting	Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell NCT05353439	National Cancer Institute (NCI)	Phase 1
Terminated	Bomedemstat and Maintenance Immunotherapy for Treatment of Newly Diagnosed Extensive Stage Small Cell Lung Can NCT05191797	University of Washington	Phase 1 / Phase 2
Recruiting	S1827 (MAVERICK) Testing Whether the Use of Brain Scans Alone Instead of Brain Scans Plus Preventive Brain Rad NCT04155034	SWOG Cancer Research Network	Phase 3
Active Not Recruiting	Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell C NCT03896503	National Cancer Institute (NCI)	Phase 2
Active Not Recruiting	Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) NCT03811002	National Cancer Institute (NCI)	Phase 3
Terminated	Tumor Treating Fields (TTFields) Therapy to Manage Brain Metastases in Small Cell Lung Cancer NCT03995667	OHSU Knight Cancer Institute	Phase 2